Trial Profile
Exploratory study on inflammatory immune response related to endothelial dysfunction in HIV-infected naive patients treated with abacavir compared to tenofovir-based regimens.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Abacavir (Primary) ; Efavirenz (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms ABRACADABRA
- 14 Jun 2011 New trial record